Charles Schwab Investment Management Inc Blueprint Medicines Corp Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 501,135 shares of BPMC stock, worth $57.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
501,135
Previous 476,063
5.27%
Holding current value
$57.8 Million
Previous $43.9 Million
8.26%
% of portfolio
0.01%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding BPMC
# of Institutions
313Shares Held
60.6MCall Options Held
634KPut Options Held
691K-
Black Rock Inc. New York, NY6.45MShares$743 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.31MShares$727 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.25MShares$720 Million0.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$481 Million0.07% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.5MShares$288 Million6.2% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.88B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...